Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81

被引:28
作者
Cao, J
Zhao, P
Miao, XH
Zhao, LJ
Xue, LJ
Qi, ZT
机构
[1] Second Mil Med Univ, Dept Microbiol, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Chagnzheng Hosp, Dept Infect Dis, Shanghai 200003, Peoples R China
关键词
viral receptor; hepatitis C virus; cell-based selection; hCD81-binding peptide; phage display; HEPATITIS-C VIRUS; E2; GLYCOPROTEIN; IDENTIFICATION; BINDING; LIBRARIES; ANTAGONISTS; ANTIBODIES; PROTEINS; MUSCLE; GENE;
D O I
10.1038/sj.cr.7290190
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human CD81 (hCD81), the most recently proposed receptor of hepatitis C virus (HCV), can especifically bind to HCV envelope glycoprotein 2 (E2). In this study, hCD81 -expressing murine NIH/3T3 cells were used to select hCD81-binding peptides from a phage displayed nonapeptide library (PVIII9aaCys). Eighteen of the 75 clones selected from the library showed specific binding to the hCD81-expressing NIH/3T3 cells by enzyme linked immunosorbent assay (ELISA) and competitive inhibition test. Twelve out of the 18 clones shared the amino acid motif SPQYWTGPA. Sequence comparison of the motif showed no amino acid homology with the native HCV E2. The motif-containing phages could competitively inhibit the ability of HCV E2 binding to native hCD81-expressing MOLT-4 cells, and induce HCV E2 specific immune response in vivo. These results suggest that the selected motif SPQYWTGPA should be a mimotope of HCV E2 to bind to hCD81 molecules. Our findings cast new light on developing HCV receptor antagonists.
引用
收藏
页码:473 / 479
页数:7
相关论文
共 30 条
[1]   AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1 [J].
Akeson, AL ;
Woods, CW ;
Hsieh, LC ;
Bohnke, RA ;
Ackermann, BL ;
Chan, KY ;
Robinson, JL ;
Yanofsky, SD ;
Jacobs, JW ;
Barrett, RW ;
Bowlin, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30517-30523
[2]   Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis [J].
Binétruy-Tournaire, R ;
Demangel, C ;
Malavaud, B ;
Vassy, R ;
Rouyre, S ;
Kraemer, M ;
Plouët, J ;
Derbin, C ;
Perret, G ;
Mazie, JC .
EMBO JOURNAL, 2000, 19 (07) :1525-1533
[3]   Identification and expression of human CD81 gene on murine NIH/3T3 cell membrane [J].
Cao, J ;
Zhao, P ;
Zhao, LJ ;
Wu, SM ;
Zhu, SY ;
Qi, ZT .
JOURNAL OF MICROBIOLOGICAL METHODS, 2003, 54 (01) :81-85
[4]  
CAO J, 2001, NATL MED J CHINA, V81, P126
[5]  
Cesareni G, 1999, COMB CHEM HIGH T SCR, V2, P1
[6]   Identification of calmodulin isoform-specific binding peptides from a phage-displayed random 22-mer peptide library [J].
Choi, JY ;
Lee, SH ;
Park, CY ;
Heo, WD ;
Kim, JC ;
Kim, MC ;
Chung, WS ;
Moon, BC ;
Cheong, YH ;
Kim, CY ;
Yoo, JH ;
Koo, JC ;
Ok, HM ;
Chi, SW ;
Ryu, SE ;
Lee, SY ;
Lim, CO ;
Cho, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21630-21638
[7]  
Di Bisceglie Adrian M., 1999, American Journal of Medicine, V107, p45S
[8]   Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein [J].
Flint, M ;
Dubuisson, J ;
Maidens, C ;
Harrop, R ;
Guile, GR ;
Borrow, P ;
McKeating, JA .
JOURNAL OF VIROLOGY, 2000, 74 (02) :702-709
[9]   Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81 [J].
Flint, M ;
Maidens, C ;
Loomis-Price, LD ;
Shotton, C ;
Dubuisson, J ;
Monk, P ;
Higginbottom, A ;
Levy, S ;
McKeating, JA .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6235-6244
[10]   HIGH-AFFINITY UROKINASE RECEPTOR ANTAGONISTS IDENTIFIED WITH BACTERIOPHAGE PEPTIDE DISPLAY [J].
GOODSON, RJ ;
DOYLE, MV ;
KAUFMAN, SE ;
ROSENBERG, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7129-7133